6-(4-(1H-imidazol-1-yl)phenyl)-4,5-dihydropyridazin-3(2H)-one; UNII-6PVQ5VQW24; CI 914; Cl 914; 3-(4-imidazol-1-ylphenyl)-4,5-dihydro-1H-pyridazin-6-one; 6PVQ5VQW24; CHEMBL12831; MFCD00867109; NCGC00015547-02; 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinone; 3(2H)-Pyridazinone, 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-; Imazodan [INN]; Imazodanum [Latin]; Imazodanum; 3(2H)-Pyridazinone, 4,5-dihydro-6-(4-(1H-imidazol-1-yl)phenyl)-; Lopac-I-0782; DSSTox_CID_25160; DSSTox_RID_80710; DSSTox_GSID_45160; Lopac0_000639; MLS000862182; SCHEMBL148436; ZINC1553; Imazodan, >=99% (HPLC); DTXSID1045160; CTK8G0276; HMS2233L24; HMS3261P20; HMS3369I22; KS-000001DA; Tox21_110171; Tox21_500639; BDBM50000315; AKOS027327583; CCG-204726; LP00639; QC-1573; SDCCGSBI-0050619.P002; NCGC00015547-01; NCGC00015547-03; NCGC00015547-04; NCGC00015547-05; NCGC00094006-01; NCGC00094006-02; NCGC00261324-01; AK326183; DS-11856; SMR000326945; DB-056777; EU-0100639; FT-0630925; I 0782; 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-; SR-01000075931; SR-01000075931-1; Q27265291; 6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one; (CI-914)6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one; 6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one(CI-914); 6-(4-Imidazol-1-yl-phenyl)-4,5-dihydro-2H-pyridazin-3-one(Imazodan)